SUN-101 25 mcg BID eFlow (CS) nebulizer

DRUG2 trials

Sponsors

Sunovion Respiratory Development Inc.

Conditions

COPDChronic Obstructive Pulmonary Disease

Phase 3

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD

CompletedNCT02347761

Sunovion Respiratory Development Inc.COPD

Start: 2015-02-28End: 2015-11-30Updated: 2018-03-22

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)

CompletedNCT02347774

Sunovion Respiratory Development Inc.Chronic Obstructive Pulmonary Disease, COPD

Start: 2015-02-28End: 2015-12-31Updated: 2018-03-13

Related Papers

Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD

Pulmonary Therapy2021-07-071 citations

Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies.

2020-09-296 citations

Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4

International Journal of COPD2018-12-015 citations

Health-Related Quality of Life Improvements in Moderate to Very Severe Chronic Obstructive Pulmonary Disease Patients on Nebulized Glycopyrrolate: Evidence from the GOLDEN Studies

Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation2018-01-013 citations